All News

Controlling the chaos as a device rep – Why my “system” stunk and yours might, too

Life as a device rep is primarily reactive and can be chaotic- you’re often the last person called or thought of in the process. I always loved when I’d proactively check if any cases had been added for me at my account and hear, “Oh yeah, we added this one and it’s scheduled for….30 minutes […]

Advanced Biomedical Technologies Inc. Granted New Patent Strengthening its Core Technology

SHENZHEN, CHINA and NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) — Advanced Biomedical Technologies Inc. (OTCQB:ABMT), a developer and manufacturer of orthopaedic internal fixation devices, today announced the State Intellectual Property Office of The People’s Republic of China (“SIPO”) has issued the Company a new patent titled “Bone Fracture Plate Made of High Polymer Materials”. […]

Ceterix Announces Completion of Groundbreaking Study of Repair for Meniscal Tears Previously Thought Unrepairable

January 31, 2018 FREMONT, Calif.–(BUSINESS WIRE)–Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve a surgeon’s ability to perform minimally invasive orthopaedic procedures, today announced completion of enrollment in STITCH (A Prospective, Non-randomized, Multi-Center Investigation of All-suture-based Repair of Horizontal Meniscal Tears1), the first-ever prospective multicenter investigation of suture-based repair for patients with horizontal […]

SeaSpine Expands Ventura™ NanoMetalene® Implant Offering to Accommodate Larger Range of Posterior Procedures

Carlsbad, Calif. / Jan. 31, 2018 – SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the portfolio expansion of the Ventura™ NanoMetalene® posterior interbody device. Ventura NanoMetalene, which has been commercially available since 2015, has expanded its size offerings to accommodate a […]

Additional Strategic Funding for CartiHeal’s Ongoing AGILI-C™ IDE Clinical Study $2.5M boost by Bioventus brings latest investment round to $21M

KFAR SABA, ISRAEL and DURHAM, NC– January 31, 2018 CartiHeal, developer of the proprietary Agili-C implant for the treatment of joint surface lesions in traumatic and osteoarthritic joints, has secured a $2.5M investment from Bioventus, a global leader in orthobiologics – reflecting the growing interest in CartiHeal’s technology. Bioventus’s $2.5M boost complements CartiHeal’s latest financing […]

CollPlant Announces ADS Listing on NASDAQ

NESS ZIONA, Israel, January 31, 2018 /PRNewswire/ — CollPlant (NASDAQ: CLGN) (TASE: CLGN), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products (recombinant human, “rhCollagen”), announced that its American Depository Shares (“ADSs”) have been approved for listing on The Nasdaq Capital Market. Trading commenced on Wednesday, January 31, 2018 under the ticker symbol “CLGN”. In addition, and simultaneously, […]

Camber Spine Reports Strong Performance Results for 2017

WAYNE, Pa., Jan. 31, 2018 /PRNewswire/ — Camber Spine, a leading innovator in spine and medical technologies, today reports a strong finish to 2017 with record fourth quarter sales and year-over-year growth. 2017 was by all accounts a very strong year for Camber Spine with 54.2% growth in Q4 and 46% year-over-year growth largely driven by an increase […]

IMPLANET: Update on the L&K BIOMED Partnership

January 30, 2018 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0010458729, PEA-PME eligible; OTCQX: IMPZY) (Paris:ALIMP) (OTCQX:IMPZY), a medical technology company specializing in vertebral and knee-surgery implants has released a progress update on the partnership it entered into with South Korean company L&K BIOMED Co. Ltd in December 2017. On December 6, IMPLANET […]

Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results

WARSAW, Ind., Jan. 30, 2018 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and full year ended December 31, 2017.  The Company reported fourth quarter net sales of $2.074 billion, an increase of 3.0% over the prior year period, and an increase of 1.5% on a constant currency basis.  Diluted earnings […]

Medicrea Reports Directors’ Dealings Disclosure

January 30, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA Group (Euronext Growth: FR0004178572 – ALMED), pioneering the convergence of healthcare IT and next-generation, outcome-centered device design and manufacturing with UNiD® ASI technology, announces transactions on securities of the Company by its Chairman and Chief Executive Officer. In accordance with Article 19 of Regulation (EU) No […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.4